SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-026815
Filing Date
2024-08-14
Accepted
2024-08-14 16:12:36
Documents
16
Period of Report
2024-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K acrx20240814_8k.htm   iXBRL 8-K 26259
2 EXHIBIT 99.1 ex_714591.htm EX-99.1 177309
7 tlphlogo1.jpg GRAPHIC 3069
  Complete submission text file 0001437749-24-026815.txt   359233

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tlph-20240812.xsd EX-101.SCH 3409
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tlph-20240812_def.xml EX-101.DEF 11807
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlph-20240812_lab.xml EX-101.LAB 15858
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlph-20240812_pre.xml EX-101.PRE 12022
18 EXTRACTED XBRL INSTANCE DOCUMENT acrx20240814_8k_htm.xml XML 2927
Mailing Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404
Business Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404 650-216-3500
TALPHERA, INC. (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35068 | Film No.: 241207868
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)